Alcohol Septal Ablation to Reduce Heart Failure
Joshua McKay1, Sherif F Nagueh1
1Department of Cardiology, Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, 6550 Fannin, Smith Tower 677, Houston, TX 77030, USA.
Interventional Cardiology Clinics
|June 11, 2017
Summary
Alcohol septal ablation can reverse heart failure mechanisms in hypertrophic cardiomyopathy patients. This procedure offers clinical improvement for those with severe, medically refractory symptoms.
Area of Science:
- Cardiology
- Genetics
- Heart Failure
Background:
- Hypertrophic cardiomyopathy (HCM) is a common genetic heart disease.
- HCM presents with varied symptoms, but 10% develop severe heart failure.
- Medical management is often insufficient for advanced HCM-induced heart failure.
Purpose of the Study:
- To elucidate the mechanisms by which HCM causes heart failure.
- To explain how alcohol septal ablation (ASA) addresses these mechanisms.
- To highlight ASA's potential for clinical improvement in refractory HCM.
Main Methods:
- Review of mechanisms linking HCM to heart failure.
- Analysis of ASA's impact on these specific pathophysiological pathways.
- Discussion of clinical outcomes post-ASA.
Main Results:
- HCM induces heart failure through multiple pathways.
- ASA effectively targets and reverses these HCM-induced mechanisms.
- Patients undergoing ASA show significant clinical improvement.
Conclusions:
- Alcohol septal ablation is a viable therapeutic option for select HCM patients.
- ASA offers a way to reverse the pathophysiology of heart failure in HCM.
- This intervention can lead to substantial clinical benefits for refractory cases.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
551
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
01:22Heart Failure VI: Adjunct Therapies
474
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
474
01:30Heart Failure V: Medical Management
428
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
428
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
01:22Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
01:22Heart Failure Drugs: β-Blockers
1.0K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K